DV3-27492-20751
3 vaccinations
3 coded responses
25 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 952 / CA
- Registered
- 2021-03-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-03-17
Registered in v-safe
-
2021-03-17
Survey response — days 1–6 daily, dose 1MedDRA: Gait disturbance, Hypoaesthesia, Neuralgia, Neuropathy peripheral, Paraesthesia — Feeling: Fair · Site: Pain, Swelling · Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sudden onset of peripheral neuropathy. Sharp, intense nerve pain in left big toe making it difficult to walk. Started last night and still persistent today. Now accompanied by pins and needles in my feet and numbness in hands.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-17
Report sent to call center — days 1–6 daily, dose 1Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-03-18
Survey response — days 1–6 daily, dose 1MedDRA: Neuropathy peripheral — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Still some peripheral neuropathy, though it seems to be diminishing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-03-20
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-21
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Joint pains, Muscle or body achesAdult check-in
-
2021-03-22
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-23
Health check-in — day 7, dose 1Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-01
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-04-09
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — day 7, dose 2Feeling: Poor · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-20
Survey response — day 14, dose 2MedDRA: Fatigue, Hypersomnia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activitiesFree text: Extreme fatigue. Sleeping 8+ hours overnight, waking, sleeping another 3 hours, waking again for a couple hours, sleeping another 4-5 hours. And repeat. Off and on for 10 days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-27
- 2021-05-04
- 2021-05-13
- 2021-05-18
- 2021-07-06
- 2021-10-05
-
2021-10-19
Dose 3 — Pfizer-BioNTech
- 2022-03-02
- 2022-04-06
- 2022-04-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-10-19 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 5 — days 1–6 daily, dose 1
Systemic reaction (other): Sudden onset of peripheral neuropathy. Sharp, intense nerve pain in left big toe making it difficult to walk. Started last night and still persistent today. Now accompanied by pins and needles in my feet and numbness in hands.
Systemic reaction (other): Still some peripheral neuropathy, though it seems to be diminishing.
Release 7 — day 14, dose 2
Symptoms: Extreme fatigue. Sleeping 8+ hours overnight, waking, sleeping another 3 hours, waking again for a couple hours, sleeping another 4-5 hours. And repeat. Off and on for 10 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Hypersomnia | ✓ | ✓ | ✓ |
| SRO | Gait disturbance | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Neuralgia | ✓ | ✓ | ✓ |
| SRO | Neuropathy peripheral | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release